Separate indirect from direct evidence (SIDE) using back-calculation method

Fixed effects model: 

            comparison k prop  nma direct indir. RoR z p-value
   eszopiclone:doxepin 0    0 1.14      .   1.14   . .       .
     melatonin:doxepin 0    0 0.87      .   0.87   . .       .
       placebo:doxepin 1 1.00 1.01   1.01      .   . .       .
 eszopiclone:melatonin 0    0 1.31      .   1.31   . .       .
   eszopiclone:placebo 1 1.00 1.12   1.12      .   . .       .
     melatonin:placebo 1 1.00 0.85   0.85      .   . .       .

Random effects model: 

            comparison k prop  nma direct indir. RoR z p-value
   eszopiclone:doxepin 0    0 1.14      .   1.14   . .       .
     melatonin:doxepin 0    0 0.87      .   0.87   . .       .
       placebo:doxepin 1 1.00 1.01   1.01      .   . .       .
 eszopiclone:melatonin 0    0 1.31      .   1.31   . .       .
   eszopiclone:placebo 1 1.00 1.12   1.12      .   . .       .
     melatonin:placebo 1 1.00 0.85   0.85      .   . .       .

Legend:
 comparison - Treatment comparison
 k          - Number of studies providing direct evidence
 prop       - Direct evidence proportion
 nma        - Estimated treatment effect (OR) in network meta-analysis
 direct     - Estimated treatment effect (OR) derived from direct evidence
 indir.     - Estimated treatment effect (OR) derived from indirect evidence
 RoR        - Ratio of Ratios (direct versus indirect)
 z          - z-value of test for disagreement (direct versus indirect)
 p-value    - p-value of test for disagreement (direct versus indirect)
[1] "Percent of comparisons where there is some evidence (p-value<0.05) of disagreement between direct and indirect sources: NaN. (0 out of 0 comparisons)."
[1] "File created on 2022-04-11"
